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tember 11, 2013.he aim of this study was to assess the impact of atherosclerotic renal artery stenosis (ARAS) on outcomes after
open-heart surgery (OHS).Background Acute kidney injury after OHS portends signiﬁcant morbidity and mortality.Methods Data from all adult patients undergoing OHS from January 2000 to April 2010 who underwent renal duplex
ultrasound were prospectively collected. ARAS was severe (60% to 99% stenosis) if peak systolic velocity was
>200 cm/s. The associations between ARAS and post-operative reduction in glomerular ﬁltration rate (GFR), need
for renal replacement therapy, length of stay, and overall short-term and long-term mortality (up to 8 years) were
tested using multivariate time-to-event adjusted analysis.Results A total of 714 patients were evaluated, with a mean age of 67  12 years (63% men) and a mean GFR of
52  25.9 ml/min/1.73 m2. A total of 206 (29%) had ARAS; of these, 79% (n ¼ 163) had unilateral and 21%
(n ¼ 43) had bilateral ARAS. ARAS was associated with peripheral artery disease (p ¼ 0.004) and lower high-density
lipoprotein levels (p ¼ 0.04). Patients with advanced age (p ¼ 0.01) and descending aorta grafting (p ¼ 0.004) had
signiﬁcant post-operative reductions in GFR. Adjusted models showed a nonsigniﬁcant trend between ARAS and
reduction in GFR (p ¼ 0.09). ARAS was not associated with need for renal replacement therapy (p ¼ 0.4), longer
length of stay (p¼ 0.7), or mortality (p¼ 0.7), but low pre-operative GFR was a strong predictor of long-termmortality.Conclusions ARAS does not appear to be associated with post-operative change in GFR, need for hemodialysis, longer length of
stay, or mortality in patients undergoing OHS. (J Am Coll Cardiol 2014;63:310–6) ª 2014 by the American
College of Cardiology FoundationAcute kidney injury (AKI) after open-heart surgery (OHS)
portends signiﬁcant morbidity and mortality (1–3).
Depending on the deﬁnitions used, post-operative AKI
occurs in 3% to 30% of patients, and AKI requiring renal
replacement therapy (RRT) develops in 1% to 5% of pati-
ents (1,2). The latter group has a mortality of 60% compared
with an overall mortality of 2% to 8% after OHS (3). Patients
with AKI have a 4-fold increased risk for short-term and
long-term death. In fact, increases in serum creatinine have
an exponential association with risk for 30-day mortality
(<0.5 mg/dl from baseline associated with a 3-fold risk and
>0.5 mg/dl increase associated with an 18-fold increased
risk) (3). The underlying pathophysiology of AKI afterscular Medicine, Heart & Vascular Institute,
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factors, including intraoperative hypotension and complica-
tions that impair renal perfusion or lead to atheroembolic
or thromboembolic events to the kidneys (2).
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Atherosclerotic renal artery stenosis (ARAS) is common
and ranges in incidence from 25% to 38% in patients with
established atherosclerotic vascular disease (4). However, the
impact of ARAS on post-operative glomerular ﬁltration rate
(GFR) and clinical outcomes is unknown. We sought to
study the impact of ARAS on post-operative change in
GFR, AKI with need for RRT, length of stay, and overall
short-term and long-term mortality.
Methods
Study population. Using the Cardiovascular Information
Registry, we identiﬁed 37,000 consecutive patients age
>18 years, undergoing ﬁrst-time OHS from January 2000
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311to April 2010. This registry contains detailed demographic,
clinical, pathologic, operative, and outcome variables on all
patients undergoing cardiac surgery at Cleveland Clinic,
abstracted from clinical records concurrent with patient care.
The Cardiovascular Information Registry follow-up infor-
mation was supplemented using the Social Security Death
Index for mortality data. This database was cross-referenced
with a vascular ultrasound database to identify 714 patients
who had undergone renal vascular ultrasound in the 90 days
before or after OHS. We collected follow-up information at
30, 60, and 90 days and yearly. These registries are approved
for use in research by the institutional review board.
Deﬁnitions. GFR was calculated using the Modiﬁcation of
Diet in Renal Disease study formula: GFR (ml/min/
1.73 m2) ¼ 186.3  serum creatinine (mg/dl)  1.154 
age (years)  0.203 ( 1.212 if black or  0.742 if female)
(5). Renal artery stenosis was deﬁned using the renal ultra-
sound criteria measuring peak systolic velocity (PSV) and
end-diastolic velocity and the renal/aortic resistive index
(RAR). The renal ultrasound deﬁnitions used were 0% to
59% (PSV <200 cm/s and RAR <3.5), 60% to 99%
(PSV 200 cm/s and RAR 3.5), >80% (PSV 200 cm/s,
RAR 3.5, and end-diastolic volume >150 cm/s), and
occluded (100%) in the absence of ﬂow (6).
Endpoints. Primary endpoints included pre-discharge
GFR and the degree of change in GFR over time.
Secondary endpoints included in-hospital morbidy and
mortality, length of stay, and long-term all-cause mortality.
Statistical analysis. Simple descriptive statistics were used to
summarize the data. Continuous variables are presented as
mean SD and as 15th, 50th (median), and 85th percentiles.
Categorical data are described using frequencies and percents,
and comparisons weremade usingWilcoxon rank sum tests or
chi-square tests. Transformations of scale were performed on
continuous variables to meet statistical model assumptions,
and the results of regression models are presented with their
coefﬁcients rather than odds or hazard ratios.
A number of variables examined in the multivariate
analyses had missing values (ranging from 0% to 22%). A
5-fold Markov-chain Monte Carlo imputation technique
was used to impute the missing values (7). Estimates of
regression coefﬁcients and their variance covariance obtained
for each of the imputed datasets were then combined to yield
the ﬁnal regression estimates and p values using PROC
MIANALYZE in SAS version 9.0 (SAS Institute Inc.,
Cary, North Carolina).
Factors associated with graded ARAS and need for RRT
were identiﬁed using multivariate cumulative and binary
logistic regression models using PROC LOGISTIC in
SAS. Variables affecting length of stay were identiﬁed using
multivariate linear regression using PROC REG in SAS.
Temporal trend analysis and factors inﬂuencing change in
pre-discharge GFR were analyzed using longitudinal
regression model P-1 (PROC MIXED in SAS) (8).
Survival was assessed nonparametrically using the Kaplan-
Meier method and parametrically using a multiphase hazardmode. Variable selection (with
a p-value criterion for retention
of variables in the model) used
bootstrap bagging (bootstrap
aggregation) (9,10). This was
a 4-step process. First, a new
dataset was created by randomly
selecting patients with replace-
ment from the original dataset.
Second, risk factors were identi-
ﬁed using an automated forward
stepwise selection. Third, the
results of the variable selection
were stored. These 3 steps were
repeated 1,000 times. Finally, the
frequency of occurrence of vari-
ables related to group membership was ascertained and
indicated the reliability of each variable (bootstrap aggrega-
tion step).
Random forest analysis (RFA). Random forest regression
was performed as a conﬁrmatory sensitivity analysis for the
impact of renal artery stenosis on operative length of stay and
need for dialysis in 714 patients using 1,000 trees. Using this
machine learning tool, we were able to identify and depict
the relationships of selected baseline variables with the
binary (need for RRT) and continuous (length of stay)
variables, as shown in Figure 1. The classiﬁcation or
regression tree method constructs a tree by recursive binary
partitioning of the data into regions that are increasingly
homogenous with respect to the binary or continuous
response variables (10–12). The classiﬁcation accuracy was
improved by aggregating the results of many trees, each
grown from a “bootstrap” dataset formed by random
sampling of the data. We constructed 1,000 trees for
random forest classiﬁcation modeling and used 20 variables
to split each node using the randomForest package in R
(R Foundation for Statistical Computing, Vienna, Austria)
(11). There were no pre-speciﬁed assumptions regarding
variables, and randomization was introduced into this model
by both random bootstrap sampling of patients from the
original cohort and random sampling of variables for each
tree branch. The random forest approach is preferable when
it is necessary to depict a complex relationship (linear or
nonlinear) between a predictor and an outcome variable. It is
also used to identify the complex interaction effect (if any)
among predictors and an outcome.
Power calculation. A power analysis was performed for the
endpoint of need for dialysis on the basis of a sample size of
584 patients with 12% requiring dialysis using multivariate
logistic regression. The calculated power of this logistic
regression to detect a signiﬁcant difference was >90%.Results
Baseline characteristics. The demographic, pre-operative
laboratory, and operative characteristics are listed in
Figure 1 Example of a Random Forest Tree
A bootstrap sample of patients from the original dataset is used to create a random tree. At the true trunk (root node), a random set of variables are chosen to be candidates,
and the most predictive values among those are identiﬁed (e.g., probability of dialysis). (A) Node levels are numbered on the basis of the distance from the true trunk (i.e., 0, 1,
2, etc.). Splitting continues until the terminal nodes have a few endpoints (e.g., dialysis). (B) Larger tree is noted with multiple levels and terminal nodes.
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312Table 1. In this study of mostly men with normal renal
function, there was a high incidence of risk factors for
atherosclerosis and established atherosclerotic vascular
disease. The most common OHS performed was coronary
artery bypass graft surgery, followed by aortic valve
replacement or repair. The use of intraoperative support
devices and blood products was low. None of the patients in
this analysis underwent renal artery balloon angioplasty,
stent implantation, or bypass surgery before OHS. In
addition, none of the patients with ARAS underwent renal
nuclear scanning before OHS.
Prevalence of ARAS and risk factors for ARAS. The
distribution of renal ultrasound studies relative to the date of
OHS is shown in Online Figure 1. Of the total patients,
29% (n ¼ 206) had ARAS; of these, 79% (n ¼ 163) had
unilateral and 21% (n ¼ 43) had bilateral renal artery
stenosis (60% to 99%), as shown in Table 1. The unadjusted
comparisons of patient and procedural characteristics that
were associated with a higher grade of ARAS were prior
peripheral artery disease, carotid artery disease, older age,
lower body mass index, and need for coronary artery bypass
grafting. On multivariate analysis, the independent predic-
tors of a higher grade of ARAS (no renal artery stenosis vs.
unilateral vs. bilateral renal artery stenosis) were a history
of prior peripheral artery disease (p ¼ 0.004), female sex
(p ¼ 0.0005), presence of low high-density lipoprotein
(p ¼ 0.04), low body mass index (p ¼ 0.0002), and older age
(p ¼ 0.008), as shown in Table 2. In addition, on multi-
variate analysis, the predictors of bilateral ARAS versus
unilateral ARAS were history of peripheral artery disease,
female sex, and older age.
Association between ARAS and GFR. An unadjusted
temporal trend analysis showed that post-operative GFR
changed signiﬁcantly over time. There was no difference in
the average GFR or minimal GFR in patients with noARAS, unilateral ARAS, or bilateral ARAS (Online
Table 1). The unadjusted graded effect of the presence of
ARAS on post-operative GFR showed a nonsigniﬁcant
association (p ¼ 0.07). A late separation was noted between
ARAS and GFR; however, this was not statistically signif-
icant (Online Figs. 2a and 2b). On multivariate analysis,
patients with lower GFR were signiﬁcantly older, had
hypertension, had diabetes, and had endocarditis. In addi-
tion, patients who underwent aortic surgery or coronary
artery bypass grafting without the use of internal mammary
artery grafts were more likely to have lower post-operative
GFR, as shown in Table 3. Further subgroup analysis
conﬁrmed no association between ARAS and change in
GFR, even when the groups with no ARAS and unilateral
ARAS were combined and compared with the group with
bilateral ARAS (p ¼ 0.40).
Multivariate predictors of the need for RRT. Patients
with lower platelet counts, histories of diabetes requiring
insulin, need for left ventricular support, and any aortic
surgery had a higher likelihood of requiring RRT in the
post-operative period, as shown in Table 3. When ARAS
was considered a binary variable (yes or no) or as an ordinal
variable, it was not associated with need for RRT. A
conﬁrmatory RFA was performed with the top 3 predictors
(pre-operative platelet count, pre-operative hematocrit, and
body surface area) in conjunction with the study variable
(presence or absence of ARAS) on the probability of needing
RRT (Online Figs. 3a and 3b). These ﬁgures do not show
a noticeable effect of the presence of ARAS on the proba-
bility of needing RRT. Furthermore, when we combined
the groups with no ARAS and unilateral ARAS and
compared them with the group with bilateral ARAS, we
found no association with need for RRT (p ¼ 0.50).
ARAS and its association with length of stay. Female sex,
need for prior ventricular assist device, and any aortic surgery
Table 1 Characteristics of the Study Cohort
Patient-related variables
Men 449 (63%)
Myocardial infarction 309 (43%)
Congestive heart failure 309 (43%)
Peripheral artery disease 212 (30%)
Hypertension 638 (89%)
Pharmacologically treated diabetes 253 (36%)
Chronic obstructive pulmonary disease 191 (27%)
Smoking 464 (65%)
Stroke/cerebrovascular accident 133 (19%)
Unilateral ARAS 163 (23%)
Bilateral ARAS 43 (6%)
Pre-operative laboratory values
Hemoglobin (g/dl) 11  1.9
HDL cholesterol (mg/dl) 44  15
LDL cholesterol (mg/dl) 91  42
Creatinine (mg/dl) 1.68  0.99
GFR (MDRD equation) 52.3  26
Procedure-related variables
Procedure
Coronary artery bypass graft 433 (61%)
Aortic valve repair/replacement 255 (36%)
Mitral valve repair/replacement 172 (24%)
Any aortic root, ascending aorta, arch replacement 132 (18%)
Support devices
Intra-aortic balloon pump 25 (3.5%)
Extracorporeal membrane oxygenation 3 (0.42%)
Left ventricular assist device 12 (1.7%)
Total myocardial ischemia (min) 75  45
Total cardiopulmonary bypass (min) 108  59
Total circulatory arrest (min) 3.3  10.7
Values are n (%) or mean  SD.
ARAS ¼ atherosclerotic renal artery stenosis; GFR ¼ glomerular ﬁltration rate; HDL ¼ high-
density lipoprotein; LDL ¼ low-density lipoprotein; MDRD ¼ Modiﬁcation of Diet in Renal Disease.
Table 3
Multivariate Analysis Showing Patient and Procedural
Factors Associated With Lower Pre-Discharge GFR,
Renal Replacement Therapy, and Longer Operative
Length of Stay
Variable Coefﬁcient  SE p Value Reliability* (%)
Lower GFR
Agey 3.5  1.3 0.01 100
MI 2.9  1.4 0.40 100
Endocarditis 7.8  2.9 0.009 100
Hypertension 9.4  2.3 <0.001 100
Diabetes 4.5  1.5 0.003 100
Bilirubinz 0.46  0.17 0.009 100
Descending aorta
grafting
8.4  2.9 0.004 100
No ITA graft 3.2  1.5 0.04 100
Pre-operative GFR 31  1.3 <0.001 100
ARAS stenosis 0.027  1.6 >0.90
Renal replacement
therapy
Diabetes 0.85  0.33 0.01 52
Lower platelet
countx
0.33  0.12 0.009 50
History of any
assist device
(pre-operative)
1.02  0.41 0.01 43
Descending aorta
grafting
1.2  0.39 0.002 98
ARAS stenosis 0.23  0.28 0.40 18
Longer length of stay
Female sex 0.20  0.053 0.001 88
History of any
assist device
0.53  0.103 <0.001 93
Lower cholesteroljj 0.042  0.019 0.03 97
History of COPD 0.17  0.058 0.003 74
History of CHF 0.13  0.055 0.02 69
Higher BUN{ 0.16  0.049 0.001 90
Aortic surgery 0.41  0.11 <0.001 100
ARAS stenosis 0.021  0.056 0.70 15
*Number of occurrences out of 1,000 bootstrap models. y(50/age) inverse transformation. z(Bili-
rubin)2 squared transformation. x(420/platelets) inverse transformation. jj(200/cholesterol)2
inverse squared transformation. {Log(BUN) logarithmic transformation.
BUN ¼ blood urea nitrogen; CHF ¼ congestive heart failure; COPD ¼ chronic obstructive
pulmonary disease; ITA ¼ internal thoracic artery; MI ¼ myocardial infarction; other abbreviations
as in Table 1.
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313were all associated with longer length of stay, as shown in
Table 3. However, in the risk-adjusted models, the presence
of ARAS as a binary variable or as an ordinal variable
(graded effect) did not inﬂuence length of stay. Additionally,
RFA using the 3 strongest predictors of increased length
of stay (isolated coronary artery bypass grafting, need for
a ventricular assist device, and cholesterol levels) found no
effect of ARAS on operative length of stay (Online Fig. 4).
Furthermore, when the groups with no ARAS and unilateralTable 2
Multivariate Analysis of Risk Factors Associated With
the Presence of Atherosclerotic Renal Artery Stenosis
Variable Coefﬁcient  SE p Value Reliability* (%)
Peripheral artery
disease
0.51  0.18 0.004 60
Female 0.65  0.18 <0.001 40
Agey 0.27  0.10 0.008 64
HDLz 0.29  0.13 0.04 78
BMIx 0.72  0.19 <0.001 97
*Number of occurrences out of 1,000 bootstrap models. yExp(age/50) exponential transformation.
z(HDL/40)2 squared transformation. x(BMI/25)2 squared transformation.
BMI ¼ body mass index; HDL ¼ high-density lipoprotein; SE ¼ standard error.ARAS were combined and compared with the group with
bilateral ARAS, we found no association with operative
length of stay (p ¼ 0.60).
Multivariate predictors of all-cause death. The median
follow-up duration was 3 years, with a total of 2,501 patient-
years available for the analysis. A multiphase hazard analysis
yielded 2 different overlapping risk periods (phases), an early
peaking risk for death (approximately up to 1 year) followed
by a constant risk for death (beyond 1 year). The parametric
estimates of survival for this group of patients was 95% at
1 month, 83% at 6 months, 79% at 1 year, 66% at 3 years,
55% at 5 years, and 42% at 8 years. On multivariate analysis,
the risk factors for early death included older age, diabetes,
congestive heart failure, lower hematocrit, and any tricuspid
valve or aortic procedure, as shown in Table 4. The risk
factors for late death included older age, history of
Table 4
Patient and Procedural Factors Associated With
Incremental Risk for Death After Open-Heart Surgery
Mortality Coefﬁcient  SD p Value Reliability* (%)
Early hazard phase
Agey 0.47  0.16 0.003 71
Weight/height ratioz 0.75  0.29 0.01 71
Platelet count
(<420,000/ml)x
0.42  0.095 <0.001 65
COPD 0.79  0.28 0.004 50
Tricuspid valve 1.03  0.29 <0.001 99
Aortic surgery 1.1  0.27 <0.001 99
Insertion of assist
device
1.6  0.36 <0.001 99
ARAS stenosis 0.22  0.27 0.40 45
Constant hazard phase
Agey 0.36  0.089 <0.001 96
Weight/height ratioz 0.41  0.18 0.02 56
COPD 0.37  0.15 0.02 54
CHF 0.34  0.14 0.02 49
Lower GFRk 0.34  0.072 <0.001 64
Lower hematocrit# 1.3  0.32 <0.001 93
Diabetes 0.46  0.15 0.002 56
Tricuspid valve
surgery
0.46  0.21 0.03 94
ARAS stenosis 0.034  0.15 0.80 16
*Number of occurrences out of 1,000 bootstrap models. yExp(age/50) exponential transformation.
z(1/[weight/height ratio]) inverse transformation. x(420/Pre-operative platelet count) inverse
transformation. k(50/Pre-operative GFR) inverse transformation. #(Hematocrit/30)2 squared
transformation.
Abbreviations as in Tables 1 and 3.
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314congestive heart failure, and lower GFR, as shown in
Table 4. The presence of ARAS or the graded level of
ARAS did not appear to be associated with risk for death
(early or late death) (Figs. 2a and 2b, Table 4). Furthermore,
when the groups with no ARAS and unilateral ARAS were
combined and compared with the group with bilateral
ARAS group, we found no association with all-cause death
(p > 0.60).Discussion
This study adds to the limited body of evidence doc-
umenting the impact of ARAS on renal dysfunction and
mortality after OHS (13). In addition, it builds on these
ﬁndings by using a more reliable estimate of renal function
(GFR), examines a variety of outcomes in addition to
operative mortality, and assesses the impact of ARAS on
long-term mortality. We demonstrate there is no association
between the presence of ARAS and signiﬁcant change in
GFR or lowest GFR after OHS. Additionally, there is no
association between ARAS and mortality, length of inten-
sive care unit stay, or need for RRT.
Renal dysfunction after OHS and ARAS may share
renal ischemia as a common pathophysiological mechanism
(14). The mechanism of renal injury may be different with
AKI in OHS (as seen in hypotension), affecting glomerular
function while chronic renal hypoperfusion (seen in ARAS)results in intrarenal compensatory mechanisms that preserve
glomerular perfusion at the expense of parenchymal ischemia
(15). Autopsy studies of patients with ARAS have shown
predominant tubulointerstitial atrophy (parenchymal injury)
with glomerular sparing, suggesting relative preservation of
glomerular reserve and capacity to tolerate hypoperfusion
(16). Furthermore, deterioration of renal function in the
presence of ARAS may not reﬂect “true ischemia” under
normal conditions, because blood ﬂow to the kidney is far in
excess of metabolic needs (17). Moderate reductions in
blood ﬂow, as in ARAS, may not be the sole or even the
major contributor to reduced renal function (18). The view
that reduction in renal blood ﬂow directly results in ischemic
damage may be overly simplistic. Additionally, there does
not appear to be a tight relationship between renal artery
diameter and loss of GFR (19). In studies of moderate renal
artery stenosis (50% to 70%), GFR ranged from 30 to
38 ml/min and was unrelated to renal artery diameter (20).
Furthermore, the time to end-stage renal disease in patients
with ARAS was the same irrespective of the degree of renal
artery stenosis, and paradoxically, the Cox proportional
hazard analysis of risk for developing end-stage renal disease
indicated that moderate ARAS > 50% was more of a risk
(relative risk [RR]: 3.39) than severe ARAS (relative risk:
0.95) (19). Corollaries to these observations are noted in the
clinical trials assessing endovascular treatment for ARAS for
preservation of renal function. These studies would, in
theory, serve to attenuate the impact of renal artery stenosis
on renal function. Among others, the 2 most contemporary
prospective studies using angioplasty and stent implantation
were the Stent Placement and Blood Pressure and Lipid-
Lowering for the Prevention of Progression of Renal
Dysfunction Caused by Atherosclerotic Ostial Stenosis of
the Renal Artery and Angioplasty and Stenting for Renal
Artery Lesion trials, which showed no clear association
between endovascular intervention and decline in GFR
(despite some limitations) (21–23). Our study is in keeping
with these randomized trials, suggesting that treatment for
ARAS does not prevent renal dysfunction.
The impact of an atherosclerotic lesion may relate to its
effects not only on perfusion pressure but also on the duration
of the hemodynamic insult, effects on kidney parenchyma
due to hypertensive nephrosclerosis, and recurrent athe-
roembolic insults (23). Despite strategies to minimize renal
dysfunction, we note that among others, the need for pre-
operative hemodynamic support and aortic surgery was
associated with increased risk for RRT (24). These factors
are minimized in the current planning for contemporary
OHS and post-operative management. In our study, inde-
pendent of baseline GFR, ARAS was associated with
a marginal decline in the rate of recovery of GFR in the latter
stages after OHS on the temporal trend analysis. This may
reﬂect a delayed capacity for renal recovery in response to
ischemia due to the presence of ARAS.
We also show that the presence of ARAS does not
affect short-term or long-term mortality, but a low GFR
Figure 2 Overall Survival After Surgery Stratiﬁed by ARAS Grade and by the Presence of ARAS
(A) Overall survival stratiﬁed by presence (yellow lines) and absence (blue lines) of atherosclerotic renal artery stenosis. (B) Overall survival stratiﬁed by grade of athero-
sclerotic renal artery stenosis (ARAS). Blue lines and dots = no ARAS; yellow lines and dots = unilateral ARAS; red lines and dots = bilateral ARAS. Each symbol represents
a death positioned on the vertical axis by Kaplan-Meier estimator, vertical bars are conﬁdence limits equivalent to 1 standard error. Solid lines are parametric survival estimates
enclosed within dashed 68% conﬁdence bands equivalent to 1 SD.
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315(<50 ml/min/1.73 m2) is a predictor of long-term mortality
(>1 year). These ﬁndings are in contrast with those of prior
studies that showed signiﬁcantly higher mortality in patients
with ARAS (25,26). The majority of studies testing the
association between ARAS and overall mortality were
limited by small sample sizes and design issues (retrospective
and case-control studies). The largest study used Medicare
claims data (n ¼ 1,085,250) from 1999 to 2001 and showed
that patients with ARAS had signiﬁcantly higher rates of
atherosclerotic disease, with a higher rate of triple ischemic
endpoints (myocardial infarction, stroke, and death) (27,28).
However, this study was retrospective, observational, and
cross-sectional by design, making these data open to con-
founding factors. In addition, these observations were made
in an era without contemporary medical therapy, making
them of limited clinical relevance. We similarly show that
patients with ARAS have a higher burden of established
atherosclerotic disease, require more aortocoronary grafts,
and tend to require more hemodynamic support, but we do
not show any association with mortality. We note that long-
term mortality is associated with baseline GFR and not the
presence of ARAS (29).
We also used RFA to test the interaction of various
variables in affecting our outcomes. There are 4 advantages
to using RFA. First, the RFA method is intuitive because
important variables to predict an endpoint can be identiﬁed
by inspecting the tree trunks and simpliﬁed in a ﬁgure
plotting the minimal depth of a variable from the tree trunk.
Second, RFA do not require analysts to know in advance the
relationship (i.e., linear, nonlinear) of a variable over time or
to choose the best equation to transform nonlinear cova-
riates. Third, the complex interactions among multiplevariables can be easily understood with RFA. Finally, the
overall accuracy of an RFA model is at least comparable to
standard methodologies (10). RFA is a well-known and
highly used machine learning method and has been used
successfully in several applied settings, including staging for
esophageal cancer (12).
Study limitations. First, it was observational in nature, and
despite adjustment for confounders in the multivariate
analysis, we can only investigate associations and cannot
infer causality. Second, there were no differences in baseline
GFR between the 2 groups, but the 2 groups studied fall
into the category of chronic kidney disease, which may mask
the true effect of ARAS on renal function and outcomes.
Third, we allowed renal ultrasound studies up to 90 days
after OHS; this could have produced selection bias.
However, only 15% of renal ultrasound studies were per-
formed after OHS, and a subgroup analysis excluding these
patients did not reveal an association between ARAS and
the endpoints of ARAS, length of stay, or need for RRT.
Fourth, given the moderate sample size, the lack of an
association between ARAS and operative and long-term
outcomes after OHS may be due to inadequate power.
Fifth, renal artery ultrasound may not be the best method to
determine the clinical signiﬁcance of ARAS, and novel tools
such as direct pressure assessment may better determine the
clinical signiﬁcance of the ARAS in this setting (30).
Conclusions
We have shown no association between the presence of
ARAS and change in GFR or lower GFR, need for RRT,
length of intensive care unit stay, or mortality. ARAS found
during ultrasound examination of the renal arteries in the
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316post-operative period after OHS should be managed
conservatively. What is unclear is the best management
strategy with bilateral ARAS or severe unilateral ARAS in
the highest risk category, as in patients undergoing aortic
surgery or in those needing hemodynamic support.
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